SAB Biotherapeutics (NASDAQ:SABS – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, risk, profitability, dividends and earnings. Analyst Ratings This is a breakdown of current ratings […]
SAB Biotherapeutics (NASDAQ:SABS – Get Rating) and Sutro Biopharma (NASDAQ:STRO – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, dividends, risk, institutional ownership, profitability and valuation. Volatility and Risk SAB Biotherapeutics has a beta of […]
SAB Biotherapeutics, Inc. (NASDAQ:SABS – Get Rating) has earned an average rating of “Buy” from the three brokerages that are covering the company, MarketBeat reports. Two analysts have rated the stock with a buy rating. The average 1 year price objective among brokerages that have updated their coverage on the stock in the last year […]